Helicobacter pylori persistence: Biology and disease

Journal of Clinical Investigation

Volumn 113, Issue 3, 2004, Pages 321-333

  Blaser, Martin J ^a   Atherton, John C ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; HELICOBACTER PYLORI; IMMUNE RESPONSE; INFECTION RISK; MICROFLORA; NONHUMAN; PEPTIC ULCER; POPULATION STRUCTURE; PRIORITY JOURNAL; REVIEW; STOMACH; STOMACH TUMOR; HELICOBACTER INFECTION; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; STOMACH DISEASE; VIRULENCE;

GHRELIN; LEPTIN; PEPTIDE HORMONE;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; LEPTIN; PEPTIDE HORMONES; STOMACH; STOMACH DISEASES; VIRULENCE;

EID: 85047691456     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI20925     Document Type: Review

References (125)

1. Blaser, M.J., and Kirschner, D. 1999. Dynamics of Helicobacter pylori colonization in relation to the host response. Proc. Natl. Acad. Sci. U. S. A. 96:8359-8364.
2. Nomura, A.M.Y., et al. 2002. Helicobacter pylori cagA seropositivity and gastric carcinoma risk in a Japanese American population. J. Infect. Dis. 186:1138-1144.
3. Helicobacter and Cancer Collaborative Group. 2001. Gastric cancer and Helicobacter pylori: a combined analysis of twelve case-control studies nested within prospective cohorts. Gut. 49:347-353.
4. Peek, R.M., and Blaser, M.J. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer. 2:28-37.
5. Azuma, T., et al. 2001. Gastric leptin and Helicobacter pylori infection. Gut. 49:324-329.
6. Nwokolo, C.U., Freshwater, D.A., O'Hare, P., and Randeva, H.S. 2003. Plasma ghrelin following cure of Helicobacter pylori. Gut. 52:637-640.
7. Blaser, M.J. 1998. Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in the modern era. Gut. 43:721-727.
8. Ghose, C., et al. 2002. East Asian genotypes of Helicobacter pylori: strains in Amerindians provide evidence for its ancient human carriage. Proc. Natl. Acad. Sci. U. S. A. 99:15107-15111.
9. Falush, D., et al. 2003. Traces of human migration in Helicobacter pylori populations. Science. 299:1582-1585.
10. Blaser, M.J., and Berg, D.E. 2001. Helicobacter pylori genetic diversity and risk of human disease. J. Clin. Invest. 107:767-773.
11. Kuipers, E.J., et al. 2000. Quasispecies development of Helicobacter pylori observed in paired isolates obtained years apart in the same host. J. Infect. Dis. 181:273-282.
12. Suerbaum, S., et al. 1998. Free recombination with Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A. 95:12619-12624.
13. Bjorkholm, B., et al. 2001. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A. 98:14607-14612.
14. Sjolund, M., Wreiber, K., Andersson, D.I., Blaser, M.J., and Engstrand, L. 2003. Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann. Intern. Med. 139:483-487.
15. Falush, D., et al. 2001. Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age: Proc. Natl. Acad. Sci. U. S. A. 98:15056-15061.
16. Aras, R.A., Kang, J., Tschumi, A., Harasaki, Y., and Blaser, M.J. 2003. Extensive repetitive DNA facilitates prokaryotic genome plasticity. Proc. Natl. Acad. Sci. U. S. A. 100: 13579-13584.
17. Aras, R.A., Takata, T., Ando, T., Van der Ende, A., and Blaser, M.J. 2001. Regulation of the Hpy11 restriction-modification system of Helicobacter pylori by gene deletion and horizontal reconstitution. Mol. Microbiol. 42:369-382.
18. Wang, G., Ge, Z., Rasko, D.A., and Taylor, D.E. 2000. Lewis antigens in Helicobacter pylori: biosynthesis and phase variation. Mol. Microbiol. 36:1187-1196.
19. Tomb, J.F., et al. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 388:539-547.
20. Pride, D.T., and Blaser, M.J. 2002. Concerted evolution between duplicated genetic elements in Helicobacter pylori. J. Mol. Biol. 316:629-642.
21. Xu, Q., Morgan, R.D., Roberts, R.J., and Blaser, M.J. 2000. Identification of type II restriction and modification systems in Helicobacter pylori reveals their substantial diversity among strains. Proc. Natl. Acad. Sci. U. S. A. 97:9671-9676.
22. Ilver, D., et al. 1998. Helicobacter pylori adhesion binding fucosylated histo-blood group antigens revealed by retagging. Science. 279:373-377.
23. Pride, D.T., Meinersmann, R.J., and Blaser, M.J. 2001. Allelic variation within Helicobacter pylori babA and babB. Infect. Immun. 69:1160-1171.
24. Cover, T.L., Dooley, C.P., and Blaser, M.J. 1990. Characterization and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect. Immun. 58:603-610.
25. Crabtree, J.E., et al. 1991. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet. 338:332-335.
26. Nomura, A.M.Y., Perez-Perez, G.I., Lee, J., Stemmerman, G., and Blaser, MJ. 2002. Relationship between H. pylori cagA status and risk of peptic ulcer disease. Am. J. Epidemiol. 155:1054-1059.
27. Blaser, M.J., et al. 1995. Infection with Helicobacter pylori strains possessing cagA associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115.
28. Kersulyte, D., Chalkauskas, H., and Berg, D.E. 1999. Emergence of recombinant strains of Helicobacter pylori during human infection. Mol. Microbiol. 31:31-43.
29. Tummuru, M.K.R., Sharma, S.A., and Blaser, M.J. 1995. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 18:867-876.
30. Odenbreit, S., et al. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 287:1497-1500.
31. Segal, E.D., Cha, J., Lo, J., Falkow, S., and Tompkins, L.S. 1999. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. U. S. A. 96:14559-14564.
32. Yamazaki, S., et al. 2003. The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J. Infect. Dis. 187:334-337.
33. Aras, R.A., et al. 2003. Natural variation in populations of persistently colonizing bacteria affect human host cell phenotype. J. Infect. Dis. 188:486-496.
34. Selbach, M., Moese, S., Hauck, C.R., Meyer, T.F., and Backert, S. 2002. Src is the kinase of Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem. 277:6775-6778.
35. Higashi, H., et al. 2002. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 295:683-686.
36. Mimuro, H., et al. 2002. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell. 10:745-755.
37. Tsutsumi, R., Higashi, H., Higuchi, M., Okada, M., and Hatakeyama, M. 2003. Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J. Biol. Chem. 278:3664-3670.
38. Selbach, M., et al. 2003. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J. 22:515-528.
39. Guillemin, K., Salama, N., Tompkins, L., and Falkow, S. 2002. Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc. Natl. Acad. Sci. U. S. A. 99:15136-15141.
40. - strains. Gut. 50:295-298.
41. Cover, T.L., and Blaser, M.J. 1992. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 267:10570-10575.
42. Cover, T.L., Tummuru, M.K.R., Cao, P., Thompson, S.A., and Blaser, M.J. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J. Biol. Chem. 269:10566-10573.
43. Atherton, J., et al. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:17771-17777.
44. Iwamoto, H., Czajkowsky, D.M., Cover, T.L., Szabo, G., and Shao, Z. 1999. VacA from Helicobacter pylori: a hexameric chloride channel. FEBS Lett. 450:101-104.
45. Tombola, F., et al. 2001. The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J. Clin. Invest. 108:929-937. doi:10.1172/JC1200113045.
46. Papini, E., et al. 1998. Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J. Clin. Invest. 102:813-820.
47. Zheng, P.Y., and Jones, N.L. 2003. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell. Microbiol. 5:25-40.
48. Molinari, M., et al. 1998. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187:135-140.
49. Gebert, B., Fischer, W., Weiss, E., Hoffmann, R., and Haas, R. 2003. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science. 301:1099-1102.
50. Pai, R., Covet, T.L., and Tatnawski, A.S. 1999. Helicobacter pylori vacuolating cytotoxin (VacA) disorganizes the cytoskeletal architecture of gastric epithelial cells. Biochem. Biophys. Res. Commun. 262:245-250.
51. Kuck, D., et al. 2001. Vacuolating cytotoxin of Helicobacter pylori induces apoptosis in the human gastric epithelial cell line AGS. Infect. Immun. 69:5080-5087.
52. Cover, T.L., Krishna, U.S., Israel, D.A., and Peek, R.M., Jr. 2003. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res. 63:951-957.
53. Ogura, K., et al. 2000. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J. Exp. Med. 192:1601-1610.
54. Fujikawa, A., et al. 2003. Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat. Genet. 33:375-381.
55. Letley, D.P., and Atherton, J.C. 2000. Natural diversity in the N terminus of the mature vacuolating cytotoxin of Helicobacter pylori determines cytotoxin activity. J. Bacteriol. 182:3278-3280.
56. Letley, D.P., Rhead, J.L., Twells, R.J., Dove, B., and Atherton, J.C. 2003. Determinants of non-toxicity in the gastric pathogen Helicobacter pylori. J. Biol. Chem. 278:26734-26741.
57. Atherton, J.C., Peek, R.M., Tham, K.T., Cover, T.L., and Blaser, M.J. 1997. The clinical and pathological importance of heterogeneity in vacA, encoding the vacuolating cytotoxin of Helicobacter pylori. Gastroenterology. 112:92-99.
58. Kidd, M., Lastovica, A.J., Atherton, J.C., and Louw, J.A. 1999. Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? Gut. 45:499-502.
59. Miehlke, S., et al. 2000. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int. J. Cancer. 87:322-327.
60. Alm, R.A., et al. 1999. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 397:176-180.
61. Asahi, M. 2003. Helicobacter pylori CagA containing ITAM-like sequences localized to lipid rafts negatively regulates VacA-induced signaling in vivo. Helicobacter. 8:1-14.
62. Amieva, M.R., et al. 2003. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science. 300:1430-1434.
63. Dubois, A., et al. 1996. Transient and persistent experimental infection of non-human primates with Helicobacter pylori: implications for human disease. Infect. Immun. 64:2885-2891.
64. Perez-Perez, G.I., et al. 2003. Transient and persistent Helicobacter pylori colonization in Native American children. J. Clin. Microbiol. 41:2401-2407.
65. Peek, R.M., et al. 1995. Heightened inflammatory response and cytokine expression to cagA* Helicobacter pylori strains. Lab. Invest. 73:760-770.
66. Warren, J.R., and Marshall, B. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1:1273-1275.
67. Mai, U.E.H., et al. 1992. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leucocytes and are present in gastric mucosa. J. Exp. Med. 175:517-525.
68. Maeda, S., et al. 2001. Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J. Biol. Chem. 276:44856-44864.
69. Backhed, F., et al. 2003. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J. Infect. Dis. 187:829-836.
70. Foryst-Ludwig, A., and Naumann, M. 2000. p21-activated kinase 1 activates the nuclear factor kappa B (NF-kappa B)-inducing kinase-Ikappa B kinases NF-kappa B pathway and proinflammatory cytokines in Helicobacter pylori infection. J. Biol. Chem. 275:39779-39785.
71. Giardin, S.E., et al. 2003. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science. 300:1584-1587.
72. Bamford, K.B., et al. 1998. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology. 114:482-492.
73. Wang, J., et al. 2001. Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J. Immunol. 167:926-934.
74. Wirth, H.P., Yang, M., Peek, R.M., Tham, K.T., and Blaser, M.J. 1997. Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology. 113:1091-1098.
75. Aras, R.A., et al. 2003. Plasticity of repetitive DNA sequences within a bacterial (type IV) secretion system component. J. Exp. Med. 198:1349-1360.
76. Allen, L.A., Schlesinger, L.S., and Kang, B. 2000. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J. Exp. Med. 191:115-128.
77. Atherton, J.C., Tham, K.T., Peek, R.M., Cover, T.L., and Blaser, M.J. 1996. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. J. Infect. Dis. 174:552-556.
78. Mohammadi, M., et al. 1997. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology. 113:1848-1857.
79. Fox, J.G., et al. 2000. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat. Med. 6:536-542.
80. Guiney, D.G., Hasegawa, P., and Cole, S.P. 2003. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect. Immun. 71:4163-4166.
81. Smythies, L.E., et al. 2000. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J. Immunol. 165:1022-1029.
82. Blaser, M.J. 1993. Malaria and the natural history of Helicobacter pylori infection. Lancet. 342:551. (Letter)
83. Machado, J.C., et al. 2003. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology. 125:364-371.
84. El-Omar, E., et al. 2000. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 404:398-402.
85. El-Omar, E.M., et al. 2003. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 124:1193-1201.
86. Beales, I.L., and Calam, J. 1998. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut. 42:227-234.
87. Moss, S.F., Legon, S., Bishop, A.E., Polak, J.M., and Calam, J. 1992. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet. 340:930-932.
88. Levi, S., et al. 1989. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet. 1:1167-1168.
89. Chowers, M.Y., et al. 2002. A defined human gastrin sequence stimulates the growth of Helicobacter pylori. FEMS Microbiol. Lett. 217:231-236.
90. El-Omar, E.M., et al. 1995. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology. 109:681-691.
91. Gillen, D., et al. 1998. The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. Gastroenterology. 114:50-57.
92. Hamlet, A., and Olbe, L. 1996. The influence of Helicobacter pylori infection on postprandial duodenal acid load and duodenal bulb pH in humans. Gastroenterology. 111:391-400.
93. Khulusi, S., et al. 1996. Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration. Gastroenterology. 110:452-458.
94. Ohkusa, T., et al. 2003. Helicobacter pylori infection induces duodenitis and superficial duodenal ulcer in Mongolian gerbils. Gut. 52:797-803.
95. Peek, R.M., Jr., et al. 1997. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J. Natl. Cancer Inst. 89:863-868.
96. Peek, R.M., Jr., et al. 2000. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology. 118:48-59.
97. Kuipers, E.J., et al. 1995. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 345:1525-1528.
98. Yamaji, Y., et al. 2001. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut. 49:335-340.
99. Koike, T., et al. 2001. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut. 49:330-334.
100. Baron, J.H., and Sonnenberg, A. 2001. Period- and cohort-age contours of deaths from gastric and duodenal ulcer in New York 1804-1998. Am. J. Gastroenterol. 96:2887-2891.
101. El-Serag, H.B., and Sonnenberg, A. 1998. Opposing time trends of peptic ulcer and reflux disease. Gut. 43:327-333.
102. Chow, W.H., et al. 1998. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 58:588-590.
103. Vaezi, M.F., et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am. J. Gastroenterol. 95:2206-2211.
104. Rothenbacher, D., Blaser, M.J., Bode, G., and Brenner, H. 2000. An inverse relationship between gastric colonization by Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study. J. Infect. Dis. 182:1446-1449.
105. Sobhani, I., et al. 2002. Vagal stimulation rapidly increases leptin secretion in human stomach. Gastroenterology. 122:259-263.
106. Goiot, H., et al. 2001. Antral mucosa expresses functional leptin receptors coupled to STAT-3 signaling, which is involved in the control of gastric secretions in the rat. Gastroenterology. 121:1417-1427.
107. Asakawa, A., et al. 2001. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 120:337-345.
108. Lee, H.M., et al. 2002. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology. 143:185-190.
109. Nishi, Y., et al. 2003. The relationship between ghrelin and Helicobacter pylori infection. Helicobacter. 8:402. (Abstr.)
110. Mueller, A., et al. 2003. Protective immunity against Helicobacter is characterized by a unique transcriptional signature. Proc. Natl. Acad. Sci. U. S. A. 100:12289-12294.
111. Parsonnet, J. 1995. The incidence of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 9:45-51.
112. Nomura, A., et al. 1991. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 325:1132-1136.
113. Hansson, L.E., et al. 1993. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology. 105:1098-1103.
114. Simpson, A.J., Caballero, O.L., and Pena, S.D. 2001. Microsatellite instability as a tool for the classification of gastric cancer. Trends Mol. Med. 7:76-80.
115. Wagner, S., et al. 1997. Regulation of gastric epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology. 113:1836-1847.
116. Meyer-ter-Vehn, T., et al. 2000. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the protooncogenes c-fos and c-jun. J. Biol. Chem. 275:16064-16072.
117. Naumann, M., et al. 1999. Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J. Biol. Chem. 274:31655-31662.
118. Maeda, S., et al. 2002. Analysis of apoptotic and antiapoptotic signaling pathways induced by Helicobacter pylori. Mol. Pathol. 55:286-293.
119. Fan, X.J., et al. 1998. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J. Exp. Med. 187:1659-1669.
120. Rudi, J., et al. 1998. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J. Clin. Invest. 102:1506-1514.
121. Smoot, D.T., et al. 2000. Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury. Carcinogenesis. 21:2091-2095.
122. Kim, J.J., et al. 2002. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology. 23:542-553.
123. Ruiz, B., et al. 1994. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am. J. Gastroenterol. 89:533-539.
124. Blaser, M.J. 1997. The ecology of Helicobacter pylori in the human stomach. J. Clin. Invest. 100:759-762.
125. Lederberg, J. 2000. Infectious history. Science. 288:287-293.